Trial Profile
Clinical study of recombinant human adenovirus type 5 (H101) combined with PD-1 antibody in the treatment of advanced solid tumors
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs H-101 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 31 Aug 2018 New trial record